Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Comment by need2stockupon Feb 29, 2012 7:16am
281 Views
Post# 19602781

RE: RE: What's up with Synera?

RE: RE: What's up with Synera?

Mr. 99. That article was a 2009 article. That was 3 years ago. I guess a re-launch is long overdue because Endo didn't like the drug. We have bought 2 rejected drug products and we are hoping we can resell them again most likely to the same Doctors. Nuvo/Zars should of been smart and changed the names. The Doctors are going to say....oh that drug. I can't see this going very far. As well this November Pennsaid's market exclusivity is over and generic versions will be open to be sold if they have FDA approval. According to Nuvo's January presentation chart 2011 sales are no where near Voltaren and the Flector patch. It seems that Pennsaid Gel (Pennsaid 2%) will be the only one to work in the market. Wait a minute Voltaren is a Gel and is the top seller in the market. Second place again or third or what ever. The Car guys are going to acquire more drugs to meet end points to get raises in wages not in the stock price. Need2.

Bullboard Posts